Corus Pharma develops pharmaceutical products that address unmet needs in infectious disease and respiratory disorders. Acquired by Gilead Sciences, Inc. in August 2006
Corus Pharma develops pharmaceutical products that address unmet needs in infectious disease and respiratory disorders. Acquired by Gilead Sciences, Inc. in August 2006